Mechanisms underlying arginine vasopressin-induced relaxation in monkey isolated coronary arteries

被引:61
作者
Okamura, T [1 ]
Ayajiki, K [1 ]
Fujioka, H [1 ]
Toda, N [1 ]
机构
[1] Shiga Univ Med Sci, Dept Pharmacol, Ohtsu, Shiga 5202192, Japan
关键词
arginine vasopressin (AVP); coronary artery; EDRF; monkey; nitric oxide (NO); V-1 vasopressin receptor;
D O I
10.1097/00004872-199917050-00011
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective The present study was undertaken to examine whether arginine vasopressin (AVP) relaxes primate coronary artery and to analyse the mechanisms of its action in reference to endothelial nitric oxide and AVP receptor subtype. Methods Isometrical tension responses to AVP and desmopressin were recorded in isolated monkey coronary arteries. Results AVP (10(-9) to 10(-7) mol/l) induced a concentration-related relaxation; endothelium-denudation abolished the response. Treatment with N-G-nitro-L-arginine, but not the D-enantiomer, abolished the endothelium-dependent relaxation, which was restored by L-arginine, Treatment with SR49059 and [Pmp(1),Tyr(Me)(2)]-Arg(8)-vasopressin, selective inhibitors of V-1 receptor subtype, attenuated the relaxant response to AVP, whereas the relaxation induced by sodium nitroprusside was not affected by SR49059. Desmopressin, a V-2 receptor agonist, up to 10(-8) mol/l did not elicit relaxation. Conclusions it is concluded that AVP-induced monkey coronary arterial relaxation is mediated via nitric oxide synthesized from L-arginine in association with stimulation of V-1 receptor subtypes in the endothelium, J Hypertens 1999, 17:673-678 (C) Lippincott Williams & Wilkins.
引用
收藏
页码:673 / 678
页数:6
相关论文
共 29 条
[1]   NITRIC-OXIDE MAY PARTICIPATE IN V-2 VASOPRESSIN-RECEPTOR-MEDIATED RENAL VASODILATION [J].
AKI, Y ;
TAMAKI, T ;
KIYOMOTO, H ;
HE, H ;
YOSHIDA, H ;
IWAO, H ;
ABE, Y .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 (02) :331-336
[2]   [ARG(8)]VASOPRESSIN-INDUCED RESPONSES OF THE HUMAN ISOLATED CORONARY-ARTERY - EFFECTS OF NONPEPTIDE RECEPTOR ANTAGONISTS [J].
BAX, WA ;
VANDERGRAAF, PH ;
STAM, WB ;
BOS, E ;
NISATO, D ;
SAXENA, PR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 285 (02) :199-202
[3]   VASCULAR-RESPONSES TO VASOPRESSIN ANTAGONISTS IN MAN AND RAT [J].
BURRELL, LM ;
PHILLIPS, PA ;
ROLLS, KA ;
BUXTON, BF ;
JOHNSTON, CI ;
LIU, JJ .
CLINICAL SCIENCE, 1994, 87 (04) :389-395
[4]   ENDOTHELIAL L-ARGININE PATHWAY AND RELAXATIONS TO VASOPRESSIN IN CANINE BASILAR ARTERY [J].
COSENTINO, F ;
SILL, JC ;
KATUSIC, ZS .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (02) :H413-H418
[5]   ARGININE VASOPRESSIN INDUCES ENDOTHELIUM-DEPENDENT VASODILATATION OF THE PULMONARY-ARTERY - V(1)-RECEPTOR-MEDIATED PRODUCTION OF NITRIC-OXIDE [J].
EVORA, PRB ;
PEARSON, PJ ;
SCHAFF, HV .
CHEST, 1993, 103 (04) :1241-1245
[6]   Regional differences in the arterial response to vasopressin: Role of endothelial nitric oxide [J].
GarciaVillalon, AL ;
Garcia, JL ;
Fernandez, N ;
Monge, L ;
Gomez, B ;
Dieguez, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (07) :1848-1854
[7]   VASOPRESSIN-MEDIATED FOREARM VASODILATION IN NORMAL HUMANS - EVIDENCE FOR A VASCULAR VASOPRESSIN V2 RECEPTOR [J].
HIRSCH, AT ;
DZAU, VJ ;
MAJZOUB, JA ;
CREAGER, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (02) :418-426
[8]  
HRUBY VJ, 1990, ANNU REV PHARMACOL, V30, P501, DOI 10.1146/annurev.pa.30.040190.002441
[9]   VASOPRESSIN CAUSES ENDOTHELIUM-DEPENDENT RELAXATIONS OF THE CANINE BASILAR ARTERY [J].
KATUSIC, ZS ;
SHEPHERD, JT ;
VANHOUTTE, PM .
CIRCULATION RESEARCH, 1984, 55 (05) :575-579
[10]   ANTAGONISM OF VASOPRESSIN-INDUCED CORONARY-ARTERY CONSTRICTION BY THE VASOPRESSIN ANTAGONIST D(CH2)5TYR(ME)-AVP [J].
KOPIA, GA ;
VALOCIK, RE .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (05) :958-963